1. Home
  2. RCKT vs CRSR Comparison

RCKT vs CRSR Comparison

Compare RCKT & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • CRSR
  • Stock Information
  • Founded
  • RCKT 1999
  • CRSR 1994
  • Country
  • RCKT United States
  • CRSR United States
  • Employees
  • RCKT N/A
  • CRSR N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • CRSR Computer Manufacturing
  • Sector
  • RCKT Health Care
  • CRSR Technology
  • Exchange
  • RCKT Nasdaq
  • CRSR Nasdaq
  • Market Cap
  • RCKT 764.5M
  • CRSR 1.1B
  • IPO Year
  • RCKT N/A
  • CRSR 2020
  • Fundamental
  • Price
  • RCKT $7.18
  • CRSR $7.46
  • Analyst Decision
  • RCKT Strong Buy
  • CRSR Buy
  • Analyst Count
  • RCKT 10
  • CRSR 6
  • Target Price
  • RCKT $44.10
  • CRSR $10.00
  • AVG Volume (30 Days)
  • RCKT 3.2M
  • CRSR 1.2M
  • Earning Date
  • RCKT 05-08-2025
  • CRSR 05-06-2025
  • Dividend Yield
  • RCKT N/A
  • CRSR N/A
  • EPS Growth
  • RCKT N/A
  • CRSR N/A
  • EPS
  • RCKT N/A
  • CRSR N/A
  • Revenue
  • RCKT N/A
  • CRSR $1,348,872,000.00
  • Revenue This Year
  • RCKT N/A
  • CRSR $16.15
  • Revenue Next Year
  • RCKT N/A
  • CRSR $10.40
  • P/E Ratio
  • RCKT N/A
  • CRSR N/A
  • Revenue Growth
  • RCKT N/A
  • CRSR N/A
  • 52 Week Low
  • RCKT $4.55
  • CRSR $5.60
  • 52 Week High
  • RCKT $26.98
  • CRSR $13.02
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 46.92
  • CRSR 51.40
  • Support Level
  • RCKT $6.21
  • CRSR $6.18
  • Resistance Level
  • RCKT $8.26
  • CRSR $7.55
  • Average True Range (ATR)
  • RCKT 0.58
  • CRSR 0.45
  • MACD
  • RCKT 0.03
  • CRSR 0.18
  • Stochastic Oscillator
  • RCKT 28.05
  • CRSR 89.22

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.

Share on Social Networks: